QA: OMEROS CORP in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2017_OMEROS_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001285819, OMEROS CORP

  xvar xval
0 AssetsCurrent 60,262,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,181,000
3 remainder_Assets 5,835,000
4 LiabilitiesCurrent 16,071,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,782,000
9 ResearchAndDevelopmentExpense 50,699,000
10 remainder_Expenses 9,231,000
11 remainder_Revenues 41,617,000
12 remainder_NetIncome -4,650,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 67,278,000
1 Liabilities 16,071,000
2 Expenses 103,712,000
3 Revenues 41,617,000
4 StockholdersEquity 51,207,000
5 NetIncome -66,745,000
6 ComprehensiveNetIncome -66,745,000
7 BaseVar 116,664,000
8 EconomicCapitalRatio 0.512

Edgar->Model Mapping

Feature Distribution